Economic Returns to R&D Spending
|
|
Company
|
Patents / $1M R&D spend
|
|
1
|
Vertex
|
0.81
|
|
2
|
Allergan
|
0.46
|
|
3
|
Celgene
|
0.23
|
|
4
|
Bristol-Myers Squibb
|
0.22
|
|
5
|
Gilead
|
0.16
|
|
5
|
Regeneron
|
0.16
|
|
7
|
Biogen Idec
|
0.13
|
|
8
|
AbbVie
|
0.12
|
|
9
|
Novo Nordisk
|
0.11
|
|
9
|
Pfizer
|
0.11
|
|
9
|
Shire
|
0.11
|
|
12
|
AstraZeneca
|
0.10
|
|
12
|
Roche
|
0.09
|
|
12
|
Amgen
|
0.09
|
|
15
|
Sanofi
|
0.09
|
|
16
|
GlaxoSmithKline
|
0.09
|
|
17
|
Merck
|
0.08
|
|
18
|
Johnson & Johnson
|
0.07
|
|
19
|
Bayer
|
0.07
|
|
20
|
Novartis
|
0.05
|
|
21
|
Eli Lilly
|
0.05
|
|
22
|
Alexion
|
0.03
|